449 related articles for article (PubMed ID: 17972818)
1. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
Jovanović-Mićić D; Samardzić R; Beleslin B
Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
[TBL] [Abstract][Full Text] [Related]
2. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
Jovanović-Mićić D; Janković S; Beleslin DB
Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal receptors and drugs in motility disorders.
Ruoff HJ; Fladung B; Demol P; Weihrauch TR
Digestion; 1991; 48(1):1-17. PubMed ID: 1651261
[TBL] [Abstract][Full Text] [Related]
4. The effects of drugs on intestinal motility.
Farrar JT
Clin Gastroenterol; 1982 Sep; 11(3):673-81. PubMed ID: 7140003
[No Abstract] [Full Text] [Related]
5. Molecular, functional, and pharmacological targets for the development of gut promotility drugs.
Sarna SK
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G545-55. PubMed ID: 16565417
[TBL] [Abstract][Full Text] [Related]
6. [Medicamentous modification of gastrointestinal motility and secretion].
Allescher HD
Z Gastroenterol; 1991 Apr; 29 Suppl 3():27-30. PubMed ID: 1648290
[TBL] [Abstract][Full Text] [Related]
7. [What is assured in therapy of gastrointestinal diseases with drugs acting on motility?].
Müller-Lissner S; Klauser A
Internist (Berl); 1989 Dec; 30(12):797-804. PubMed ID: 2695489
[No Abstract] [Full Text] [Related]
8. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
Manabe N; Wong BS; Camilleri M
Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
[TBL] [Abstract][Full Text] [Related]
9. [Prokinetic drugs].
Hellström P
Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341
[TBL] [Abstract][Full Text] [Related]
10. Potential pharmacological approaches to management of gut motility disorders.
Malagelada JR
Scand J Gastroenterol Suppl; 1984; 96():111-26. PubMed ID: 6382573
[TBL] [Abstract][Full Text] [Related]
11. Tachykinin receptors as drug targets for motility disorders.
Hoogerwerf WA; Sarna SK
Dig Dis; 2006; 24(1-2):83-90. PubMed ID: 16699266
[TBL] [Abstract][Full Text] [Related]
12. Prokinetics and fundic relaxants in upper functional GI disorders.
Tack J
Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266
[TBL] [Abstract][Full Text] [Related]
13. 5-HT4 receptor agonists: similar but not the same.
De Maeyer JH; Lefebvre RA; Schuurkes JA
Neurogastroenterol Motil; 2008 Feb; 20(2):99-112. PubMed ID: 18199093
[TBL] [Abstract][Full Text] [Related]
14. [Colonic motility in humans. Recent physiological, pathophysiological and pharmacological data].
Jouët P; Coffin B; Cuillerier E; Soulé JC; Flourié B; Lémann M
Gastroenterol Clin Biol; 2000 Mar; 24(3):284-98. PubMed ID: 10804335
[No Abstract] [Full Text] [Related]
15. Ion channels as targets for treatment of gastrointestinal motility disorders.
Farrugia G
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
[No Abstract] [Full Text] [Related]
16. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
Sanger GJ; Alpers DH
Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
[TBL] [Abstract][Full Text] [Related]
17. [On the possibility of using prokinetics in gastroenterology].
Sheptulin AA; Vize-Khripunova MA
Klin Med (Mosk); 2010; 88(5):19-22. PubMed ID: 21089451
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of gastrointestinal motor disorders.
Schuurkes JA
Rev Gastroenterol Mex; 1994; 59(2):165-70. PubMed ID: 7991970
[TBL] [Abstract][Full Text] [Related]
19. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders.
Peeters TL
Curr Opin Pharmacol; 2006 Dec; 6(6):553-8. PubMed ID: 17011824
[TBL] [Abstract][Full Text] [Related]
20. Motility disorders in the ICU: recent therapeutic options and clinical practice.
Röhm KD; Boldt J; Piper SN
Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):161-7. PubMed ID: 19202387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
